EIPICO pens pharmaceutical co-manufacturing deal with RTA Group

Deal valued at $35mln

  
Quality Engineer inspecting product in production process at medical industry. Image used for illustrative purpose.

Quality Engineer inspecting product in production process at medical industry. Image used for illustrative purpose.

Getty Images

ArabFinance: The Egyptian International Pharmaceutical Industries Company (EIPICO) (PHAR) signed a pharmaceutical co-manufacturing agreement with Kazakhstan’s RTA Group, according to the company’s statement filed to the Egyptian Exchange on February 8th.

Under the deal, EIPICO will transfer advanced technology for drug manufacturing to RTA Group, in addition to training its pharmaceutical and technical personnel.

Signing the deal, valued at $35 million (EGP 548.45 million), aims at promoting trade exchange between Egypt and Kazakhstan, and create opportunities for joint investment and industrialization.

EIPICO reported a 35% Year on Year decline in its consolidated net profit in the first nine months of 2020, achieving EGP 339.46 million, compared to EGP 522.19 million in the prior-period year.

EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. It is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones.

Copyright © 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Health